Filter all by:
Content Type
Theme
Team
In this report we provide colour on the ongoing engagement dialogues we have been having with our holdings.
AMR is a systemic problem, often caused by the misuse or overprescription of antimicrobial medicines.
Equities regained ground this week amid volatile trading in September.
Seoul’s new ‘Corporate Value-Up Programme’ aims to address the so-called ‘Korea discount’.
The markets’ first test is Friday’s August US jobs report. How will the Fed respond?
Investment into the Life Sciences sector looks compelling for the long term.
Load More
